Risk factors
10x Genomics (TXG) risk factors
Item 1A of every 10x Genomics, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors75 risks9 new6 dropped21 reworded
10x Genomics expanded risk disclosures around regulatory scrutiny of LDTs, clinical market entry, and evolving AI technologies.
Filed Feb 13, 2026 - FY2024 10-K risk factors72 risks
10x Genomics faces heavy reliance on academic customers and government funding like NIH grants. Operations suffer from significant ongoing net losses, reaching $182.6 million in 2024. The business depends heavily on manufacturing single-cell Chromium platforms and managing international supply chains.
Filed Feb 13, 2025